These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26216446)

  • 1. Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.
    Cacciola NA; Sepe R; Forzati F; Federico A; Pellecchia S; Malapelle U; De Stefano A; Rocco D; Fusco A; Pallante P
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1179-86. PubMed ID: 26216446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
    Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients.
    Zheng X; Zhou J; Zhang B; Zhang J; Wilson J; Gu L; Zhu B; Gu J; Ji J; Deng D
    BMC Cancer; 2015 Mar; 15():145. PubMed ID: 25881303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBX7 modulates the expression of genes critical for cancer progression.
    Pallante P; Sepe R; Federico A; Forzati F; Bianco M; Fusco A
    PLoS One; 2014; 9(5):e98295. PubMed ID: 24865347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
    Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ
    J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
    Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
    Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.
    Federico A; Sepe R; Cozzolino F; Piccolo C; Iannone C; Iacobucci I; Pucci P; Monti M; Fusco A
    Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):509-521. PubMed ID: 30826432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
    Bartling B; Lewensohn R; Zhivotovsky B
    Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression.
    Sepe R; Formisano U; Federico A; Forzati F; Bastos AU; D'Angelo D; Cacciola NA; Fusco A; Pallante P
    Oncotarget; 2015 Feb; 6(5):2680-92. PubMed ID: 25595895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
    Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
    Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB.
    Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH
    Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of CBX7 protein.
    Chen L; Xia JS; Wu JH; Chen YG; Qiu CJ
    Environ Toxicol; 2020 Nov; 35(11):1234-1240. PubMed ID: 32621571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
    Pickl JM; Tichy D; Kuryshev VY; Tolstov Y; Falkenstein M; Schüler J; Reidenbach D; Hotz-Wagenblatt A; Kristiansen G; Roth W; Hadaschik B; Hohenfellner M; Duensing S; Heckmann D; Sültmann H
    Oncotarget; 2016 Sep; 7(37):59589-59603. PubMed ID: 27449098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.
    Yu T; Wu Y; Hu Q; Zhang J; Nie E; Wu W; Wang X; Wang Y; Liu N
    Oncotarget; 2017 Apr; 8(16):26637-26647. PubMed ID: 28460453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
    Kim HY; Park JH; Won HY; Lee JY; Kong G
    FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
    Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
    Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin.
    Kaufmann SH; Kalemkerian GP; Jasti R; Mabry M
    Biochem Pharmacol; 1995 Dec; 50(12):1987-93. PubMed ID: 8849324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.
    Ruihua H; Mengyi Z; Chong Z; Meng Q; Xin M; Qiulin T; Feng B; Ming L
    Oncotarget; 2016 Dec; 7(52):87136-87146. PubMed ID: 27888624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.
    Shinjo K; Yamashita Y; Yamamoto E; Akatsuka S; Uno N; Kamiya A; Niimi K; Sakaguchi Y; Nagasaka T; Takahashi T; Shibata K; Kajiyama H; Kikkawa F; Toyokuni S
    Int J Cancer; 2014 Jul; 135(2):308-18. PubMed ID: 24375438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.